Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.72
Delayed Data
As of 3:59pm ET
 -0.01 / -0.37%
Today’s Change
1.93
Today|||52-Week Range
3.77
+28.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash96.6M147.2M314.3M349.4M
 
 
 
 
 
Short Term Investment Cash-115.2M40.6M167.2M35.1M
 
 
 
 
 
Cash & Short Term Investments189.6M242.1M409.3M435.3M
 
 
 
 
 
 
ReceivablesReceivables162.9M151.3M125.3M83.2M
 
 
 
 
 
 
InventoriesInventories1.6M2.9M3.5M11.5M
 
 
 
 
 
 
Current AssetsOther Current Assets973.0K1.7M5.9M6.9M
 
 
 
 
 
Current Assets355.1M398.0M544.0M536.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--9.2M----
 
 
Depreciation---9.2M----
 
 
Intangible Assets637.9M630.9M516.3M571.3M
 
 
 
 
 
Other Assets646.9M638.3M523.8M573.1M
 
 
 
 
 
Total Assets1.2B1.2B1.2B1.3B
 
 
 
 
 
 
LiabilitiesAccounts Payable7.1M7.0M18.0M10.4M
 
 
 
 
 
Short Term Debt0.000.00122.7M123.8M
 
 
 
Accrued Expenses2.9M24.9M30.2M25.3M
 
 
 
 
 
Other Current Liabilities103.7M115.4M121.0M119.9M
 
 
 
 
 
Other Liabilities121.5M130.3M275.3M276.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt234.9M232.4M112.4M114.0M
 
 
 
 
 
Deferred Taxes-24.2M-19.3M-11.7M-18.2M
 
 
 
 
 
Other Liabilities14.8M13.0M13.6M14.9M
 
 
 
 
 
Total Liabilities462.2M460.0M474.8M483.2M
 
 
 
 
 
 
EquityMinority Interest-3.0K-56.0K-47.0K0.00
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity749.6M751.1M758.7M818.8M
 
 
 
 
 
Total Shareholder Equity749.6M751.1M758.7M818.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding165.5M165.5M163.7M154.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.